DSG2 Expression Marks a Stromal-Immune Organizational State in Head and Neck Squamous Cell Carcinoma
Cancers · 13.08.2026 · 18 (16) · 2611
DOI: 10.3390/cancers18162611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 13.08.2026. Verfasst von Ömer Tarık Çiçek und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Marmara University, Istanbul 34854, Turkey. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Immune exclusion in head and neck squamous cell carcinoma (HNSCC) limits immunotherapy efficacy, yet the molecular determinants of stromal-immune organization remain incompletely characterized. The desmosomal cadherin DSG2 is highly expressed in squamous epithelium; its role in shaping the tumor microenvironment (TME) is unknown.
Methods
We integrated bulk RNA-seq from 836 HNSCC patients (TCGA-HNSC n = 566, GSE65858 n = 270), single-cell RNA-seq (GSE139324, n = 26 patients, 133,308 cells), spatial transcriptomics (GSE208253, n = 12), proteomics (CPTAC-HNSCC, n = 108), and external validation cohorts (GSE41613, n = 97). CellChat ligand-receptor analysis, mediation analysis, Mendelian randomization (MR), LASSO-penalized Cox regression, HPV-stratified sensitivity analysis, and transcription factor (TF) correlation analysis were employed.
Results
DSG2 exhibited epithelial-specific expression and showed consistent positive correlation with CXCL8 (IL-8; TCGA ρ = 0.228, p = 4.4 × 10−8) and myCAF activation across independent cohorts. Single-cell analysis revealed that 99.5% of CXCL8-producing cells have zero DSG2 expression, establishing the bulk correlation as compositional rather than cell-intrinsic. CellChat identified CXCL8-CXCR2 as the strongest tumor-stroma interaction in DSG2-high regions (probability = 0.821, 1.80-fold enrichment). Mediation analysis demonstrated 43.6% (95% CI [34.3–53.6%]) of DSG2’s tissue-level association with myCAF activation is mediated through CXCL8 (compositional mediation). Multi-instrument MR (IVW: Beta = −0.028, p = 0.028; I2 = 0.0%) corroborated the compositional model. Protein-level validation in CPTAC-HNSCC confirmed DSG2-CD8A inverse correlation (Spearman ρ = −0.35, p = 2.2 × 10−4). Pan-squamous meta-analysis confirmed negative DSG2-cytolytic activity correlations (pooled ρ = −0.213, 95% CI [−0.296, −0.128], I2 = 58.6%, 4 cohorts). DSG2 correlated with TIDE score (ρ = 0.176) and TGF-β exclusion subscore (ρ = 0.428). DepMap analysis identified CXCR2 inhibitor collateral sensitivity (ρ = −0.408, p < 0.0001). An eight-gene co-expression module was validated in two independent cohorts (GSE41613: HR = 3.09, p = 0.003; GSE65858: HR = 1.57, p = 0.032).
Conclusions
DSG2 marks a stromal-immune organizational state characterized by CXCL8-CXCR2 paracrine signaling, myCAF activation, and immune exclusion, conserved across squamous malignancies. DSG2-high/PD-L1-high tumors (30.4% prevalence) exhibit the worst predicted ICI response and represent a candidate population for biomarker-selected CXCR2 inhibitor trials in combination with anti-PD-1 therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Marmara University, Istanbul 34854, Turkey.
- School of Life Sciences, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
- Department of Biochemistry, School of Medicine, Marmara University, Istanbul 34854, Turkey.
- Department of Biochemistry, School of Medicine, Recep Tayyip Erdogan University, Rize 53100, Turkey.
- Division of Medical Oncology, Goztepe Memorial Hospital Cancer Center, Istanbul 34730, Turkey.
ORCID-Profile: Muharrem Okan Çakır, Betül Karademir Yılmaz, G Hossein Ashrafi
Zitieren
APA
Çiçek, Ö. T., Çakır, M. O., Kurt, B., Yılmaz, B. K., Ashrafi, G. H., & Özdoğan, M. (2026). DSG2 Expression Marks a Stromal-Immune Organizational State in Head and Neck Squamous Cell Carcinoma. Cancers, 18(16), 2611. https://doi.org/10.3390/cancers18162611
Vancouver
Çiçek ÖT, Çakır MO, Kurt B, Yılmaz BK, Ashrafi GH, Özdoğan M. DSG2 Expression Marks a Stromal-Immune Organizational State in Head and Neck Squamous Cell Carcinoma. Cancers. 2026;18(16):2611. doi:10.3390/cancers18162611
BibTeX
@article{iek2026,
author = {Çiçek, Ömer Tarık and Çakır, Muharrem Okan and Kurt, Begüm and Yılmaz, Betül Karademir and Ashrafi, G Hossein and Özdoğan, Mustafa},
title = {DSG2 Expression Marks a Stromal-Immune Organizational State in Head and Neck Squamous Cell Carcinoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {16},
pages = {2611},
doi = {10.3390/cancers18162611}
}
EUVIMED